SCHEMBL206288

SCHEMBL206288

Cc1cccc(CC2(N(C)C)CCC(NC(=O)CCC(=O)NCCc3cccc(Cl)c3)CC2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
KMT2A Q03164 3/20 0.50
SMN1; SMN2 Q16637 4/20 0.48
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
HPGD P15428 3/20 0.43
MEN1 O00255 1/20 0.43
EPHX2 P34913 1/20 0.43
THRB P10828 2/20 0.43
CNR1 P21554 1/20 0.42
MAPT P10636 2/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL205735 0.95 ALDH1A1 (0.55) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL206578 0.93 ALDH1A1 (0.45) ALDH1A1KMT2ASMN1; SMN2HDAC3HDAC1
SCHEMBL208454 0.92 ALDH1A1 (0.53) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL207253 0.91 HDAC3 (0.43) ALDH1A1KMT2ASMN1; SMN2HDAC3HDAC1
SCHEMBL206988 0.91 ALDH1A1 (0.51) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL207581 0.91 POLB (0.46) KMT2AHPGDEPHX2THRBMAPT
SCHEMBL206736 0.91 HPGD (0.48) ALDH1A1KMT2ASMN1; SMN2HDAC3HDAC1
SCHEMBL206160 0.90 ALDH1A1 (0.49) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
Hydrochloric Acid SCHEMBL206061 0.90 ALDH1A1 (0.50) ALDH1A1KMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL205392 0.90 HPGD (0.46) ALDH1A1KMT2ASMN1; SMN2HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US claimed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US claimed
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP disclosed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD ALDH1A1 158/4885KMT2A 3604/4885SMN1; SMN2 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.